Ledger.Open graph →
SEC Form D · filed December 30, 2025

DMC Biotechnologies, Inc

Offering
$2.5M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Doug D. Cameron · Boulder, CODirectorK'Lynne Johnson · Boulder, CODirectorJosko D. Bobanovic · Boulder, CODirectorRob D. Van Der Meij · Boulder, CODirectorAlastair D. Cooper · Boulder, CODirectorJosh Yelen · Boulder, COExecMatthew L. Lipscomb · Boulder, CODirectorJim Flatt · Boulder, COExec · DirectorJim Flatt · Boulder, COExec · DirectorK'Lynne Johnson · Boulder, CODirectorHarlan M. Peltz · Los Angeles, CADirectorAndrew M. Peltz · Los Angeles, CADirectorJoseph G. Machado · Boston, MADirectorKelly Watters · Telluride, CODirectorJames F. Oliviero, Iii · Waltham, MADirectorJosh Yelen · Boulder, COExecZhong Shao · New York, NYDirectorMuhan Zou · New York, NYDirectorBryan A. Helmkamp · New York, NYDirectorLarry N. Feinberg · GREENWICH, CTDirectorDarell L. Krasnoff · LOS ANGELES, CADirectorLane W. Wiggers · Wayne, PADirectorSarah G. Roth · Wayne, PAExecTodd Cozzens · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗